Technical Analysis for RHHBY - Roche Hldg Ltd Spons

Grade Last Price % Change Price Change
grade B 33.06 -0.15% -0.0500
RHHBY closed down 0.15 percent on Tuesday, May 21, 2019, on 2.04 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Up
See historical RHHBY trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Cup with Handle Other 0.00%
Stochastic Reached Overbought Strength 0.00%
Inside Day Range Contraction 0.00%
Overbought Stochastic Strength 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.15%
Pocket Pivot Bullish Swing Setup -0.15%
Outside Day Range Expansion -0.15%
Up 3 Days in a Row Strength -0.15%
Up 4 Days in a Row Strength -0.15%

Older signals for RHHBY ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Life Sciences Pharmaceutical Industry In China Pharmaceutical Products Infectious Diseases Disease Neuroscience Gene Expression Diabetes Care Genentech Hoffmann La Roche Chugai Pharmaceutical Co. Roche
Is RHHBY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 34.98
52 Week Low 26.3
Average Volume 953,939
200-Day Moving Average 31.9487
50-Day Moving Average 33.3482
20-Day Moving Average 32.637
10-Day Moving Average 32.447
Average True Range 0.4138
ADX 21.67
+DI 24.0704
-DI 22.0542
Chandelier Exit (Long, 3 ATRs ) 32.0286
Chandelier Exit (Short, 3 ATRs ) 33.0464
Upper Bollinger Band 33.4335
Lower Bollinger Band 31.8405
Percent B (%b) 0.77
BandWidth 4.880963
MACD Line -0.1663
MACD Signal Line -0.2811
MACD Histogram 0.1148
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 33.6150
Resistance 3 (R3) 33.5600 33.3200 33.5225
Resistance 2 (R2) 33.3200 33.1787 33.3475 33.4916
Resistance 1 (R1) 33.1900 33.0913 33.2550 33.2450 33.4608
Pivot Point 32.9500 32.9500 32.9825 32.9775 32.9500
Support 1 (S1) 32.8200 32.8087 32.8850 32.8750 32.6592
Support 2 (S2) 32.5800 32.7213 32.6075 32.6284
Support 3 (S3) 32.4500 32.5800 32.5975
Support 4 (S4) 32.5050